Adagene (ADAG) announced data at the SITC 39th Annual Meeting, taking place in Houston, Nov. 6 – 10, 2024. The two poster presentations ...

Xilio is leveraging its proprietary platform to advance a pipeline of research-stage programs for tumor-activated bispecific ...

Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regu ...

Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced the presentation of new data on two of its promising investigational ...

A large population of key cells with major immunosuppressive effects are involved in immune evasion in HCC, including regulatory T (Treg) cells, myeloid-derived suppressor cells (MDSCs ... PD-1/PD-L1 ...

Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of potentially best-in-class IL-2 therapeutics, today shared positive results from its Phase 1/2 ...

Advice for first-time home buyers from Money Box Live. Irvine Welsh and Kirsty Young Seven things we learned when Irvine spoke to Kirsty. DEC Middle East Humanitarian Appeal. Appeal to help those ...

A step-by-step guide to help you fill out a W-4. Amy Fontinelle has more than 15 years of experience covering personal finance, corporate finance and investing. Lea Uradu, J.D. is a Maryland State ...

Rose is not like other girls. She's left Whitby for NYC, to take a bite of the Big Apple.

sending its U.S.-listed shares down 5.4% premarket. Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term skin condition ...

White matter hyperintensities are linked to cortical atrophy, a key feature in dementia. Here, the authors identify loci associated with cortical atrophy related to white matter hyperintensities ...